HAP1 and breast cancer: To test the metabolic switch beyond the HAP1 background, we generated a panel of SHMT2 deficient cell lines for the colorectal cancer cell line HCT116 and breast cancer cell lines MDA-MB-231, SKB3, T47D and MDA-MB-468.